GlassScriptPhysician profile
Monica Lindblad
NPI 1144094244
$635.98
in general payments reported to CMS, 2019-2025
8 companies · $531 in 2025
The $531 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $105 · 2025: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $498 · Travel and Lodging: $138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $498.34 |
| Travel and Lodging | $137.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $203.81 | 2025 | Stratafix |
| Boston Scientific Corporation | $183.81 | 2025 | General - Balloons, Angiojet Ultra 5000a, Jetstream Sc |
| Microvention, INC. | $104.55 | 2024 | Tubing Kit - Stroke |
| Integra Lifesciences Corporation | $48.39 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $38.84 | 2025 | Collagenase Santyl |
| Bard Peripheral Vascular, INC. | $24.51 | 2025 | |
| Novo Nordisk INC | $16.93 | 2025 | Wegovy |
| Pacira Pharmaceuticals Incorporated | $15.14 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Lindblad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.